UniProt ID | TM165_HUMAN | |
---|---|---|
UniProt AC | Q9HC07 | |
Protein Name | Transmembrane protein 165 | |
Gene Name | TMEM165 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 324 | |
Subcellular Localization |
Golgi apparatus membrane Multi-pass membrane protein . Golgi apparatus, trans-Golgi network membrane. Lysosome membrane. Early endosome membrane. Late endosome membrane. |
|
Protein Description | May function as a calcium/proton transporter involved in calcium and in lysosomal pH homeostasis. Therefore, it may play an indirect role in protein glycosylation.. | |
Protein Sequence | MAAAAPGNGRASAPRLLLLFLVPLLWAPAAVRAGPDEDLSHRNKEPPAPAQQLQPQPVAVQGPEPARVEKIFTPAAPVHTNKEDPATQTNLGFIHAFVAAISVIIVSELGDKTFFIAAIMAMRYNRLTVLAGAMLALGLMTCLSVLFGYATTVIPRVYTYYVSTVLFAIFGIRMLREGLKMSPDEGQEELEEVQAELKKKDEEFQRTKLLNGPGDVETGTSITVPQKKWLHFISPIFVQALTLTFLAEWGDRSQLTTIVLAAREDPYGVAVGGTVGHCLCTGLAVIGGRMIAQKISVRTVTIIGGIVFLAFAFSALFISPDSGF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
40 | O-linked_Glycosylation | AGPDEDLSHRNKEPP CCCCCCCCCCCCCCC | 32.49 | OGP | |
73 | O-linked_Glycosylation | ARVEKIFTPAAPVHT CCEEEEECCCCCCCC | 18.58 | 55833725 | |
80 | O-linked_Glycosylation | TPAAPVHTNKEDPAT CCCCCCCCCCCCCCC | 48.50 | 55833731 | |
117 | Ubiquitination | GDKTFFIAAIMAMRY CCHHHHHHHHHHHHH | 5.93 | - | |
117 | Ubiquitination | GDKTFFIAAIMAMRY CCHHHHHHHHHHHHH | 5.93 | 21963094 | |
128 | Phosphorylation | AMRYNRLTVLAGAML HHHHCHHHHHHHHHH | 15.38 | 24043423 | |
135 | Ubiquitination | TVLAGAMLALGLMTC HHHHHHHHHHHHHHH | 3.36 | - | |
135 | Ubiquitination | TVLAGAMLALGLMTC HHHHHHHHHHHHHHH | 3.36 | 22817900 | |
136 | Ubiquitination | VLAGAMLALGLMTCL HHHHHHHHHHHHHHH | 6.11 | 22817900 | |
137 | Ubiquitination | LAGAMLALGLMTCLS HHHHHHHHHHHHHHH | 4.82 | 22817900 | |
141 | Phosphorylation | MLALGLMTCLSVLFG HHHHHHHHHHHHHHH | 18.48 | 24043423 | |
144 | Phosphorylation | LGLMTCLSVLFGYAT HHHHHHHHHHHHHHH | 20.94 | 24043423 | |
145 | Ubiquitination | GLMTCLSVLFGYATT HHHHHHHHHHHHHHH | 3.11 | 21890473 | |
145 | Ubiquitination | GLMTCLSVLFGYATT HHHHHHHHHHHHHHH | 3.11 | - | |
149 | Phosphorylation | CLSVLFGYATTVIPR HHHHHHHHHHHHCHH | 8.08 | 24043423 | |
151 | Phosphorylation | SVLFGYATTVIPRVY HHHHHHHHHHCHHHH | 17.08 | 24043423 | |
152 | Phosphorylation | VLFGYATTVIPRVYT HHHHHHHHHCHHHHH | 14.31 | 24043423 | |
163 | Phosphorylation | RVYTYYVSTVLFAIF HHHHHHHHHHHHHHH | 9.18 | - | |
164 | Ubiquitination | VYTYYVSTVLFAIFG HHHHHHHHHHHHHHH | 15.93 | 21890473 | |
164 | Ubiquitination | VYTYYVSTVLFAIFG HHHHHHHHHHHHHHH | 15.93 | - | |
165 | Ubiquitination | YTYYVSTVLFAIFGI HHHHHHHHHHHHHHH | 3.01 | 22817900 | |
165 | Ubiquitination | YTYYVSTVLFAIFGI HHHHHHHHHHHHHHH | 3.01 | - | |
180 | Ubiquitination | RMLREGLKMSPDEGQ HHHHHHCCCCCCCCH | 48.46 | 21906983 | |
181 | Sulfoxidation | MLREGLKMSPDEGQE HHHHHCCCCCCCCHH | 9.39 | 30846556 | |
198 | Ubiquitination | EEVQAELKKKDEEFQ HHHHHHHHHCCHHHH | 49.64 | 21906983 | |
199 | Ubiquitination | EVQAELKKKDEEFQR HHHHHHHHCCHHHHH | 77.43 | 22817900 | |
200 | Ubiquitination | VQAELKKKDEEFQRT HHHHHHHCCHHHHHH | 69.64 | 22817900 | |
207 | Phosphorylation | KDEEFQRTKLLNGPG CCHHHHHHHCCCCCC | 18.43 | - | |
208 | Ubiquitination | DEEFQRTKLLNGPGD CHHHHHHHCCCCCCC | 53.84 | 21890473 | |
208 | Ubiquitination | DEEFQRTKLLNGPGD CHHHHHHHCCCCCCC | 53.84 | 23000965 | |
218 | Phosphorylation | NGPGDVETGTSITVP CCCCCCCCCCCCCCC | 45.68 | 28857561 | |
220 | Phosphorylation | PGDVETGTSITVPQK CCCCCCCCCCCCCCC | 25.11 | 27251275 | |
221 | Phosphorylation | GDVETGTSITVPQKK CCCCCCCCCCCCCCH | 20.01 | 25159151 | |
223 | Phosphorylation | VETGTSITVPQKKWL CCCCCCCCCCCCHHH | 26.38 | 25627689 | |
227 | Ubiquitination | TSITVPQKKWLHFIS CCCCCCCCHHHHHHH | 39.59 | 21890473 | |
227 | Ubiquitination | TSITVPQKKWLHFIS CCCCCCCCHHHHHHH | 39.59 | 21906983 | |
228 | Ubiquitination | SITVPQKKWLHFISP CCCCCCCHHHHHHHH | 50.14 | 22817900 | |
231 | Ubiquitination | VPQKKWLHFISPIFV CCCCHHHHHHHHHHH | 19.51 | 21890473 | |
231 | Ubiquitination | VPQKKWLHFISPIFV CCCCHHHHHHHHHHH | 19.51 | - | |
253 | Phosphorylation | LAEWGDRSQLTTIVL HHHHCCHHHCCEEEE | 33.99 | - | |
256 | Phosphorylation | WGDRSQLTTIVLAAR HCCHHHCCEEEEEEC | 13.57 | - | |
267 | Phosphorylation | LAAREDPYGVAVGGT EEECCCCCCEECCCH | 36.23 | 27251275 | |
274 | Phosphorylation | YGVAVGGTVGHCLCT CCEECCCHHHHHHHH | 19.86 | 27251275 | |
281 | Phosphorylation | TVGHCLCTGLAVIGG HHHHHHHHCCCEECC | 23.45 | 27251275 | |
294 | Ubiquitination | GGRMIAQKISVRTVT CCHHHHHCCCCEEEE | 28.11 | 22817900 | |
294 | Ubiquitination | GGRMIAQKISVRTVT CCHHHHHCCCCEEEE | 28.11 | 21890473 | |
296 | Phosphorylation | RMIAQKISVRTVTII HHHHHCCCCEEEEEE | 16.75 | 28787133 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TM165_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TM165_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TM165_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ARPC2_HUMAN | ARPC2 | genetic | 26472760 | |
AT2C1_HUMAN | ATP2C1 | genetic | 26472760 | |
UBE4B_HUMAN | UBE4B | genetic | 26472760 | |
PPME1_HUMAN | PPME1 | genetic | 26472760 | |
WDR62_HUMAN | WDR62 | genetic | 26472760 | |
VPS35_HUMAN | VPS35 | genetic | 26472760 | |
PTAR1_HUMAN | PTAR1 | genetic | 26472760 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
614727 | Congenital disorder of glycosylation 2K (CDG2K) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...